<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04964895</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/21/0113</org_study_id>
    <nct_id>NCT04964895</nct_id>
  </id_info>
  <brief_title>Sexual Quality of Patients After Bladder Cancer Cystectomy</brief_title>
  <acronym>QSCO</acronym>
  <official_title>Sexual Quality of Patients After Bladder Cancer Cystectomy : A Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bladder cancer is the second most prevalent urological cancer in France. About 1 in 5 new&#xD;
      cases of bladder cancer infiltrate the muscles. The standard treatment is neoadjuvant&#xD;
      chemotherapy followed by radical cystectomy associated with reconstruction of the urinary&#xD;
      tract. The short-term effects on well-being and quality of life are well known. The long-term&#xD;
      effects are, on the other hand, poorly understood, particularly sexual function. This study&#xD;
      aim to asses the quality of sexual life in patients with cystectomy for bladder cancer. This&#xD;
      will be done via various questionnaires given before and after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a prospective observational cohort study of the quality of sexual life in&#xD;
      patients with cystectomy for bladder cancer. Data is collected via Qlq-C30, EORTC-Shq22, MSHQ&#xD;
      if male, Female Sexual Function Index (FSFI) questionnaires that the patients complete by&#xD;
      themselves. They are given before surgery and then 8 months after surgery.&#xD;
&#xD;
      The study consists of the compilation of relevant clinical data and questionnaire results.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2021</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective observational study</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the decrease in the quality of sexual life of patients who had a cystectomy</measure>
    <time_frame>T0 : before surgery</time_frame>
    <description>EORTC SHQ C22 score before surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the decrease in the quality of sexual life of patients who had a cystectomy</measure>
    <time_frame>T1 : 8 months after surgery</time_frame>
    <description>EORTC SHQ C22 score 8 months after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the decrease in the quality of life of patients who had a cystectomy</measure>
    <time_frame>T0 : before surgery</time_frame>
    <description>QLQ-C30 score before surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the decrease in the quality of life of patients who had a cystectomy</measure>
    <time_frame>T1 : 8 months after surgery</time_frame>
    <description>QLQ-C30 score 8 months after surgery</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Sexual Dysfunction</condition>
  <arm_group>
    <arm_group_label>patients with cystectomy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Patients will fill in multiple questionnaires for this study :&#xD;
EORTC quality of life questionnaire (QLQ) QLQ-C30, EORTC Shq22, Male Sexual Health Questionnaire (MSHQ) only for Men, FSFI (only for women)</description>
    <arm_group_label>patients with cystectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any adult patient who had a cystectomy for bladder cancer&#xD;
&#xD;
          -  Affiliated with a social security scheme&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No Cystectomy&#xD;
&#xD;
          -  Cystectomy for neurological etiology&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Huyghe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric Huyghe, MD</last_name>
    <phone>33-0567771028</phone>
    <email>huyghe.e@chu-toulouse.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Huyghe</last_name>
      <email>huyghe.e@chu-toulouse.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 6, 2021</study_first_submitted>
  <study_first_submitted_qc>July 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bladder cancer</keyword>
  <keyword>cystectomy</keyword>
  <keyword>sex life</keyword>
  <keyword>sex quality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

